Kura Oncology, Inc. Total Assets

Quick Answer

Kura Oncology, Inc. reported Total Assets of $738.36 million for the year ending 2025.

  • Kura Oncology, Inc. showed a decrease of -2.9% in Total Assets from 2024 to 2025.
  • This data is from Kura Oncology, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2013: $18.7 thousand | Q3 2013: $15.0 thousand | Q1 2014: $6.8 thousand | Q2 2014: $4.9 thousand | Q3 2014: $18.2 thousand | Q1 2015: $54.82 million | Q2 2015: $47.53 million | Q3 2015: $42.83 million | Q1 2016: $80.38 million | Q2 2016: $81.74 million | Q3 2016: $76.30 million | Q1 2017: $61.92 million | Q2 2017: $55.85 million | Q3 2017: $103.12 million | Q1 2018: $141.46 million | Q2 2018: $129.63 million | Q3 2018: $191.50 million | Q1 2019: $169.62 million | Q2 2019: $265.69 million | Q3 2019: $254.60 million | Q1 2020: $226.46 million | Q2 2020: $353.00 million | Q3 2020: $339.57 million | Q1 2021: $620.26 million | Q2 2021: $584.89 million | Q3 2021: $561.14 million | Q1 2022: $498.59 million | Q2 2022: $471.43 million | Q3 2022: $447.99 million | Q1 2023: $425.98 million | Q2 2023: $494.74 million | Q3 2023: $473.77 million | Q1 2024: $553.91 million | Q2 2024: $515.12 million | Q3 2024: $478.84 million | Q1 2025: $743.76 million | Q2 2025: $682.43 million | Q3 2025: $649.38 million.
  • Over the full 14 years of available data (2012 to 2025), Kura Oncology, Inc.'s Total Assets has grown by 8,893,696.7%.
  • Historical annual values: Fiscal year 2025: $738.36 million | Fiscal year 2024: $760.16 million | Fiscal year 2023: $448.94 million | Fiscal year 2022: $456.31 million | Fiscal year 2021: $534.05 million | Fiscal year 2020: $647.21 million | Fiscal year 2019: $241.97 million | Fiscal year 2018: $182.38 million | Fiscal year 2017: $95.85 million | Fiscal year 2016: $69.82 million | Fiscal year 2015: $87.26 million | Fiscal year 2014: $1.38 million | Fiscal year 2013: $9.1 thousand | Fiscal year 2012: $8.3 thousand.
  • Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: